Zika virus (ZIKV) is an arthropod-borne Flavivirus that is spread by infected Aedes mosquitoes. The accurate diagnosis of ZIKV can be complicated due to a variety of factors, including analogous clinical presentation, serological cross-reactivity, or the possibility of co-infection with other co-circulated viruses such as dengue virus and chikungunya virus. Thus, the accurate and rapid diagnosis of vector-borne diseases through validated diagnostic methods is critical in enabling prompt treatment and controlling viral dissemination.
To support critical ongoing research on this virus, ATCC offers ZIKV virus reference materials and solutions for the development of novel vaccines, treatment protocols, and innovative therapeutics. Our portfolio includes in vivo and cell culture–adapted strains, genomic and synthetic nucleic acid preparations, high-titer and heat-inactivated viral preparations, monoclonal antibodies, host cell lines and reagents, and custom solutions for expansion, titering, and banking. Explore our portfolio of Zika virus research materials below.
Read our white paper to discover more about the development of Zika virus detection methodsDownload Now
Learning from Zika: Preparing for the Next Outbreak
Virology Culture Guide
Viruses are obligate intracellular pathogens that require living cells in order to multiply. The propagation of these microorganisms can vary significantly between species and can be quite challenging for isolates that have complex replication or handling requirements. That’s why we have prepared a comprehensive manual with all of our tips and tricks for handling, expanding, and preserving a wide variety of viruses.GET CULTURE TIPS